EMBC News and Press, Embecta Corp. From 09/14/22

InvestorPlace - Stock Market News, Stock Advice & Trading Tips These days the most popular stocks to follow are either meme plays or the most blue-chip S&P 500 companies. Very few investors seem to be interested in hidden gem stock picks. About halfway through September, the i...

Summary Embecta came in with a solid set of results that demonstrate its resiliency in a weakening economic outlook. Whilst company-level factors are robust for the name, as an investment proposition, metrics aren't as attractive. Shares look to be fairly priced at current ear...

Summary Matrix Asset Advisors is a Value-Driven asset management company. Our investment philosophy and process has allowed us to build a cohesive team of key investment professionals, enabling us to be both opportunistic and responsive. We think the economy is in better shape tha...

PARSIPPANY, N.J., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will participate in the following upcoming investor conferences: The 2022 Wells Fargo Healthcare Conference at the Encore Boston Harbor Hotel in Boston, Mass. ...

Embecta Corp. (EMBC) Q3 2022 Earnings Conference Call August 15, 2022 8:00 AM ET Company Participants Pravesh Khandelwal – Head-Investor Relations Dev Kurdikar – Chief Executive Officer Jake Elguicze – Chief Financial Officer Conference...

Embecta ( EMBC ) declares $0.15/share inaugural quarterly dividend . Forward yield 2.09% Payable Sept. 14; for shareholders of record Aug. 26; ex-div Aug. 25. See EMBC Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: ...

The following slide deck was published by Embecta Corp. in conjunction with their 2022 Q3 earnings call. For further details see: Embecta Corp. 2022 Q3 - Results - Earnings Call Presentation

Markets look to start trading on its back foot but shares of Accelerate Diagnostics, Inc. ( NASDAQ: AXDX ) have exploded nearly 25% after entering an agreement with Becton, Dickinson and Company ( BDX ). Also trading in the green are shares of Embecta Corp. ( NASDAQ: EMB...

Embecta press release ( NASDAQ: EMBC ): Q3 GAAP EPS of $1.07 beats by $0.20 . Revenue of $291.1M (-1.3% Y/Y) beats by $14.24M . Adjusted gross profit and margin of $203.1M and 69.8%, compared to $206.4M and 70.0% in the prior year period. Adjusted EBITDA an...

PARSIPPANY, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spin off from Becton, Dickinson and Company (“BD”), today reported financi...